Artha Sootra - Company Dashboard

Governance Classic Home

Mankind Pharma LtdPharmaceuticalsINE634S01028Consolidated₹2533.15+56.05 (+2.26%)

Valuation

Market Cap₹1.05L Cr

TTM PE46.71x

Forward PE42.84x

PEG4.78

Book Value₹425.72

P/B5.96x

TTM EPS₹54.33

Fwd EPS₹59.24

TTM Revenue₹15.38K Cr

TTM PAT₹2.26K Cr

TTM EBITDA₹4.08K Cr

TTM EBIT₹3.17K Cr

Last Qtr PAT₹716.12 Cr

Last Qtr EBITDA₹1.17K Cr

Last Qtr EBIT₹935.52 Cr

Profitability

ROE12.87%

ROCE14.60%

TTM NPM14.72%

TTM EBITDA %26.51%

Curr OPM16.16%

Last OPM14.09%

Curr NPM—

Last NPM—

Curr EPS₹17.23

Last EPS₹13.76

Balance sheet

Equity₹41.30 Cr

Reserve₹17.54K Cr

Total Debt₹5,485.68 Cr

D/E0.31x

Interest %14.65%

Curr Interest₹104.94 Cr

Price / range

Close₹2537.90

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+2.54%

1W+2.00%

1M+0.24%

3M+2.93%

6M+12.06%

1Y+7.11%

2Y-7.20%

3Y+42.95%

5Y—

Diwali+17.33%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	3,145.22+20.6%	2,964.05	2,581.82	2,632.68	2,608.78	10,421.20
Other Income	58.83	33.96	126.70	56.52	77.67	326.10
Total Income	3,204.05+19.3%	2,998.01	2,708.52	2,689.20	2,686.45	10,747.28
Interest	87.74	94.95	125.28	138.37	147.20	562.21
Expenditure	-2,420.46-12.0%	-2,241.44	-1,897.69	-2,100.49	-2,161.82	-8,326.04
PBDT	0	0	0	0	0	0
EBITDA	932.69+34.6%	928.58	918.84	778.25	693.19	3,085.94
Depreciation	-120.19	-111.02	-109.43	-107.69	-99.03	-428.57
EBIT	812.50+36.7%	817.56	809.41	670.56	594.16	2,657.37
PBT	783.59+49.4%	756.57	788.01	505.29	524.63	2,315
Tax	-201.64	-198.08	-74.40	-55.82	-65.73	-277.44
Equity	41.30	41.30	41.28	41.28	0	41.28
OPM	24.46	25.24	29.09	18.79	20.11	21.54
Net Profit	581.95+26.8%	558.49	713.61	449.47	458.90	2,037.56
NPM	18.16	18.63	26.35	16.71	17.59	18.96
EPS	14.09+26.7%	13.53	17.29	10.89	11.12	49.37

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	10,421.18+9.7%	9,497.80+2.5%	9,264.81+14.0%	8,127.15
Other Income	326.10	493.21	266.64	162.78
Total Income	10,747.28+7.6%	9,991.01+4.8%	9,531.45+15.0%	8,289.94
Expenditure	-8,326.04-8.3%	-7,685.02-5.7%	-7,271.88-8.1%	-6,727.10
Interest	-562.21	-371.76	-14.57	-27.75
PBDT	0	0	0	0
EBITDA	3,085.92+20.4%	2,562.55+10.2%	2,325.11+37.0%	1,697.38
Depreciation	-428.57	-378.01	-317.61	-269.58
EBIT	2,657.35+21.6%	2,184.54+8.8%	2,007.50+40.6%	1,427.80
PBT	2,315+0.4%	2,305.99+2.1%	2,259.57+44.6%	1,562.84
Tax	-277.44	-421.74	-436.16	-314.58
Equity	41.28	41.26	0	0
OPM (%)	21.54	23.08	24.00	19.00
Net Profit	2,037.56+4.7%	1,945.48+6.7%	1,823.41+46.1%	1,248.26
NPM (%)	18.96	19.47	19.00	15.00
EPS (Rs)	49.37-47.9%	94.80+108.3%	45.52+46.1%	31.16
CEPS	49.30	94.63	45.45	31.16

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	4,337.86+17.3%	4,030.59	3,442.93	3,567.20	3,697.16	14,277.60
Other Income	94.85	45	114.29	72.75	91.87	358.79
Total Income	4,432.71+17.0%	4,075.59	3,557.22	3,639.95	3,789.03	14,636.43
Interest	104.94	109.98	141.75	157.20	169.68	639.28
Expenditure	-3,507.28-10.7%	-3,310.08	-2,877.88	-3,027.57	-3,167.33	-12,185.69
PBDT	0	0	0	0	0	0
EBITDA	1,171.25+27.1%	1,056.19	929.88	919.43	921.33	3,617.37
Depreciation	-235.73	-225.70	-223.08	-222.60	-221.82	-886.18
EBIT	935.52+33.7%	830.49	706.80	696.83	699.51	2,731.19
PBT	925.43+48.9%	765.51	656.18	505.79	621.70	2,320.99
Tax	-212.99	-195.36	-99.75	-95.12	-103.84	-394.58
Equity	41.30	41.30	41.28	0	0	41.28
OPM	20.88	18.78	18.45	13.90	16.41	15.86
Net Profit	716.12+37.7%	574.09	559.42	413.88	520.18	1,938.10
NPM	16.16	14.09	15.73	11.37	13.73	13.24
EPS	17.23+39.1%	13.76	13.44	9.90	12.39	46.35

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	14,277.64+17.0%	12,207.44+18.1%	10,334.78
Other Income	358.79	536.79	280.86
Total Income	14,636.43+14.8%	12,744.23+20.1%	10,615.63
Expenditure	-12,185.69-19.0%	-10,240.14-24.4%	-8,231.49
Interest	-639.28	-429.41	-33.53
PBDT	0	0	0
EBITDA	3,617.41+19.9%	3,017.93+19.0%	2,535.07
Depreciation	-886.18	-621.22	-398.25
EBIT	2,731.23+14.0%	2,396.71+12.2%	2,136.82
PBT	2,320.99-7.3%	2,504.09+5.0%	2,384.15
Tax	-394.58	-509.74	-457.59
Equity	41.28	41.26	0
OPM (%)	15.86	19.65	22.46
Net Profit	1,938.10-3.6%	2,011.12+3.6%	1,941.77
NPM (%)	13.24	15.78	18.29
EPS (Rs)	46.35-5.9%	49.28+3.2%	47.75
CEPS	46.28	49.19	47.68

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Interim Dividend	1	08 Aug 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split